Physician profile
Peter Michael Grossi
NPI 1881863744
$149,235.13
in general payments reported to CMS, 2019-2025
28 companies · $3,362 in 2025
The $3,362 reported for 2025 was more than what 76% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $22K · 2021: $28K · 2022: $35K · 2023: $11K · 2024: $17K · 2025: $3,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $6,677 · Food and Beverage: $3,077 · Entertainment: $74.73 · Royalty Or License: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,640.54 |
| Travel and Lodging | $6,677.05 |
| Food and Beverage | $3,076.86 |
| Entertainment | $74.73 |
| Royalty Or License | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $101,621.41 | 2019-2025 | Concorde, Viper, Vivigen Mis Delivery System |
| Depuy Synthes Products, INC. | $17,133.66 | 2019-2022 | |
| Corelink, LLC | $8,026.62 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $7,526.47 | 2023-2024 | Exparel, Iovera, Zilretta |
| Nuvasive, INC. | $3,348.70 | 2022-2023 | Xlif, Tlx |
| Zavation Medical Products, LLC | $2,080.00 | 2024 | |
| Tricoast Surgical Solutions LLC | $1,823.25 | 2024-2025 | |
| Globus Medical, INC. | $1,198.81 | 2019-2025 | Instafill |
| Arthrex, INC. | $1,119.90 | 2024-2025 | |
| Depuy Synthes Sales INC. | $1,075.26 | 2019-2025 | Teligen |
| Restor3d, INC. | $1,000.00 | 2023 | |
| Medtronic, INC. | $560.13 | 2021-2023 | O-Arm, Catalyft Pl Expandable Interbody System |
| Integrity Implants INC. Dba Accelus | $417.80 | 2023 | |
| Osseus Fusion Systems, LLC | $300.53 | 2019 | |
| Brainlab, INC. | $299.16 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $275.65 | 2019-2020 | |
| Boston Scientific Corporation | $232.68 | 2019-2023 | |
| Osteocentric Technologies, INC. | $181.50 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Alphatec Spine, INC | $179.24 | 2019-2020 | |
| Intrinsic Therapeutics | $168.80 | 2024 | Barricaid Acd (Annular Closure Device) |
| Providence Medical Technology, INC. | $152.84 | 2019-2022 | |
| Si-Bone, INC. | $124.35 | 2019-2023 | |
| Abbott Laboratories | $119.68 | 2019-2020 | |
| Nsk America Corporation | $74.73 | 2024 | |
| Orthofix Medical, INC. | $61.70 | 2025 | 7d Surgical System |
| Integrity Implants INC. | $59.38 | 2022 | |
| Saluda Medical Americas, INC. | $38.32 | 2024 | Evoke |
| Terumo Bct, INC. | $34.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$27,052.31 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Grossi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.